Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maria Schwaederle

Showing results (1-10 of 28) with videos related to

Pageof 3
Sort By:
Oncoscience|December 19, 2015
Actionability and precision oncologyMaria Schwaederle, Razelle Kurzrock
Cancer Metastasis Reviews|July 31, 2015
Fibroblast growth factor receptor signaling in hereditary and neoplastic disease: biologic and clinical implicationsTeresa Helsten, Maria Schwaederle, Razelle Kurzrock
The New England Journal of Medicine|February 19, 2025
Trastuzumab Deruxtecan in Low or Ultralow HER2 Metastatic Breast Cancer. ReplyAditya Bardia, Maria Schwaederle, Giuseppe Curigliano
Oncotarget|July 16, 2016
An appraisal of drug development timelines in the Era of precision oncologyDenis Leonardo Jardim, Maria Schwaederle, David S Hong, et al.
European Journal of Cancer (Oxford, England : 1990)|July 21, 2017
Topoisomerase expression and amplification in solid tumours: Analysis of 24,262 patientsGregory M Heestand, Maria Schwaederle, Zoran Gatalica, et al.
Oncotarget|March 28, 2018
<i>TP53</i> mutations and number of alterations correlate with maximum standardized uptake value (SUVmax) determined by positron emission tomography/computed tomography (PET/CT) [<sup>18</sup>F] fluorodeoxyglucose (<sup>18</sup>F-FDG PET)Geraldine H Chang, Razelle Kurzrock, Lisa Tran, et al.
Journal of Hematology & Oncology|June 6, 2018
MET alterations detected in blood-derived circulating tumor DNA correlate with bone metastases and poor prognosisSadakatsu Ikeda, Maria Schwaederle, Mandakini Mohindra, et al.
Cell Cycle (Georgetown, Tex.)|June 2, 2015
Squamousness: Next-generation sequencing reveals shared molecular features across squamous tumor typesMaria Schwaederle, Sheryl K Elkin, Brett N Tomson, et al.
Cancer Metastasis Reviews|February 26, 2015
HER2 expression status in diverse cancers: review of results from 37,992 patientsMin Yan, Maria Schwaederle, David Arguello, et al.
Journal of the National Cancer Institute|February 26, 2016
ResponseDenis L Jardim, Maria Schwaederle, J Jack Lee, et al.
Pageof 3

Showing results (1-10 of 28) with videos related to

Sort By:
Pageof 3
Oncoscience|December 19, 2015
Actionability and precision oncologyMaria Schwaederle, Razelle Kurzrock
Cancer Metastasis Reviews|July 31, 2015
Fibroblast growth factor receptor signaling in hereditary and neoplastic disease: biologic and clinical implicationsTeresa Helsten, Maria Schwaederle, Razelle Kurzrock
The New England Journal of Medicine|February 19, 2025
Trastuzumab Deruxtecan in Low or Ultralow HER2 Metastatic Breast Cancer. ReplyAditya Bardia, Maria Schwaederle, Giuseppe Curigliano
Oncotarget|July 16, 2016
An appraisal of drug development timelines in the Era of precision oncologyDenis Leonardo Jardim, Maria Schwaederle, David S Hong, et al.
European Journal of Cancer (Oxford, England : 1990)|July 21, 2017
Topoisomerase expression and amplification in solid tumours: Analysis of 24,262 patientsGregory M Heestand, Maria Schwaederle, Zoran Gatalica, et al.
Oncotarget|March 28, 2018
<i>TP53</i> mutations and number of alterations correlate with maximum standardized uptake value (SUVmax) determined by positron emission tomography/computed tomography (PET/CT) [<sup>18</sup>F] fluorodeoxyglucose (<sup>18</sup>F-FDG PET)Geraldine H Chang, Razelle Kurzrock, Lisa Tran, et al.
Journal of Hematology & Oncology|June 6, 2018
MET alterations detected in blood-derived circulating tumor DNA correlate with bone metastases and poor prognosisSadakatsu Ikeda, Maria Schwaederle, Mandakini Mohindra, et al.
Cell Cycle (Georgetown, Tex.)|June 2, 2015
Squamousness: Next-generation sequencing reveals shared molecular features across squamous tumor typesMaria Schwaederle, Sheryl K Elkin, Brett N Tomson, et al.
Cancer Metastasis Reviews|February 26, 2015
HER2 expression status in diverse cancers: review of results from 37,992 patientsMin Yan, Maria Schwaederle, David Arguello, et al.
Journal of the National Cancer Institute|February 26, 2016
ResponseDenis L Jardim, Maria Schwaederle, J Jack Lee, et al.
Pageof 3